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To establish whether an enterohepatic irculation of the metabolites of vitamin D exists, polyethylene cathe- 
ters were cannulated into the portal vein of dogs. The dogs were then starved for 24 h and injected with 
cholecystokinin (CCK) to induce gall bladder contraction. At various time intervals thereafter blood sam- 
ples were collected from the portal and the saphena veins, and sera prepared and analyzed for the metabo- 
lites of vitamin D. The serum levels of 25-hydroxyvitamin D [25(OH)D] were found to be significantly higher 
in the portal blood when compared with levels in peripheral blood following CCK injection. Since portal 
blood collects nutrients absorbed from the gut and as the dogs were starved for 24 h prior to blood collec- 
tion, the only source of the increased concentrations of 25(OH)D in portal blood is likely to be bile. These 
findings support the notion that an enterohepatic irculation of 25(OH)D does exist under normal physio- 
logical conditions. 
Vitamin D; Enterohepatic irculation 
1. INTRODUCTION 
Deficiency of vitamin D is a common complica- 
tion in patients with bowel diseases and following 
surgical resection of the intestine [ 1,2]. The main 
source of vitamin D is the skin, in response to 
ultraviolet irradiation [3]. The apparent vitamin D 
deficiency in these patients is despite normal ex- 
posure to sunlight. Impaired enterohepatic ircula- 
tion of the metabolites of vitamin D could be the 
main cause of the deficiency in these patients. 
However, the existence of an enterohepatic ircula- 
tion of the metabolites of vitamin D is still a con- 
troversial issue, mainly due to the fact that very 
little of the biologically active metabolites of the 
vitamin could be detected in the bile [4,5]. In an at- 
tempt to clarify these controversies and to establish 
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whether an enterohepatic circulation of the 
metabolites of vitamin D exists, we measured 
metabolites of vitamin D in the portal and 
peripheral circulations of dogs following an i.v. in- 
jection of CCK. 
2. MATERIALS AND METHODS 
Three l-year-old dogs weighing 15 kg and in 
good nutritional status were anesthetized with 
phenobarbiton, and a polyethylene catheter of 
18 G size was cannulated into the portal vein. The 
catheter was connected to the skin in the in- 
terscapular egion. 18 h later, following 24 h star- 
vation, each dog was injected with 30 U CCK 
(Kabi Diagnostica, Studsrik, Sweden) in 3 ml 
saline and 3 ml blood samples were collected from 
the portal vein and the saphena vein at 0, 30, 45, 
60, 75, 90, and 105 min. 3 ml saline without CCK 
were injected prior to the CCK injection into the 
same dogs to serve as controls. 
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The blood samples were subjected to lipid ex- 
traction [6] and to analysis of the hydroxylated 
metabolites of vitamin D. 
25(OH)D and 24,25dihydroxyvitamin D 
[24,25(OH)zD] were measured by the competitive 
binding assay [7] following their separation on 
Sephadex LH-20 columns and utilizing diluted rat 
serum (limit of detection 0.37 ng). All samples 
were analyzed simultaneously in one assay (inter- 
assay variation 5%). 1 ,W-Dihydroxyvitamin D 
[ 1,25(OH)2D] was measured by the radioreceptor 
assay [8] utilizing intestinal receptor from rachitic 
chicks. Peaks of 1,25(0H)~D eluted off the 
Sephadex LH-20 columns were further purified on 
HPLC and analyzed simultaneously (limit of 
detection 2 pg with inter-assay variation 5%). In- 
ternal standards of authentic 3H-labelled 
metabolites were included in all plasma samples, 
for correction of recoveries during all the steps of 
the purification. 
At the end of the experiment he intestines were 
observed to confirm the absence of any food in the 
intestinal lumen. 
3. RESULTS AND DISCUSSION 
As seen from fig. 1 the levels of 25(OH)D in por- 
tal and peripheral blood of dogs are not 
significantly different. However, 60 min following 
the injection of CCK a significant rise in the level 
of 25(OH)D can be observed in the portal blood 
compared to the peripheral blood, as well, com- 
pared to time 0. Each time interval represents 
measurements of 3 blood samples obtained from 
each dog. Student’s t-test was used to establish 
significance of difference. Differences in levels of 
1,25(OH)zD and 24,25(OH)~D between portal and 
peripheral plasma were found to be insignificant. 
Injection of 3 ml saline without CCK had no effect 
on vitamin D metabolites in the portal blood. 
Vitamin D derivatives are excreted in the bile 
following i.v. injection of vitamin D. Bile analysis 
would confirm that the bile is the source of the 
25(OH)D in portal blood. However, the majority 
of the excreted derivatives appears to be more 
polar than the known hydroxylated metabolites 
[ 1,9-l 11, some of which are glucuronidated and 
therefore are not measurable [1,4]. The existence 
of an enterohepatic irculation of the metabolites 
of vitamin D is a controversial issue [4]. In an at- 
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Fig.1. Concentrations of 25(OH)D in portal and 
peripheral blood of dogs following the injection of 
CCK. For further details see text. 
tempt to establish whether such a circulation exists 
under normal physiological conditions, we tried to 
avoid in the present study any interventions, such 
as bile-duct cannulation, isotope injections, in 
order to eliminate any possible non-physiological 
stimuli. We therefore utilized normal dogs, and the 
only substance given was CCK in saline solution, 
thus causing gall bladder contraction known to oc- 
cur after every meal [12]. We were able to 
demonstrate in the present study that following the 
injection of CCK into dogs the levels of 25(OH)D 
in portal blood are elevated. Since portal blood 
collects nutrients absorbed from the gut and since 
the dogs were starved for 24 h prior to blood col- 
lections, the only source of the increased concen- 
trations of 25(OH)D is likely to be bile. Moreover, 
it is also known that 25(OH)D is absorbed in the 
gut in approximately equal amounts by both lym- 
phatic and portal systems [131. It is therefore possi- 
ble that the amounts reabsorbed from the gut are 
even higher than those observed based on portal 
blood sampling, as we did not collect lymph. 
It seems therefore that polar derivatives of 
vitamin D in bile are cleaved or transformed in the 
gut by intestinal flora or by intestinal cells back in- 
to 25(OH)D which in turn reabsorbed. This may 
explain why bile normally possesses poor an- 
tirachitic activity in spite of its large content of 
vitamin D derivatives. In summary, our findings of 
elevated levels of 25(OH)D in portal blood of 
fasting dogs following the administration of CCK 
support the notion that an enterohepatic ircula- 
tion of 25(OH)D exists under normal physiological 
conditions. Thus the bile-intestine passage is essen- 
139 
Volume 212, number 1 FEBS LETTERS February 1987 
tial in order to transform polar biliary derivatives 
of vitamin D back into active metabolites. 
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